Giuseppe Rizzi
About Giuseppe Rizzi
Giuseppe Rizzi serves as the Associate Director of Marketing for Cell Therapy at Kite Pharma, where he has worked since 2021. He has extensive educational and professional experience in pharmaceutical marketing, regulatory affairs, and project management.
Work at Kite Pharma
Giuseppe Rizzi serves as the Associate Director of Marketing for Cell Therapy at Kite Pharma. He has held this position since 2021, contributing to the company's marketing strategies in the cell therapy segment. His role involves a strong focus on launching innovative drugs in the onco-hematology area, leveraging his extensive background in marketing and product management.
Previous Experience at Gilead Sciences
Prior to his current role, Giuseppe Rizzi worked at Gilead Sciences as the Associate Director of Marketing for the Onco-Hematology franchise from 2018 to 2021. During his tenure, he was responsible for developing and executing marketing strategies that supported the franchise's growth in the oncology market.
Educational Background
Giuseppe Rizzi has a diverse educational background. He studied at Università degli Studi di Sassari, where he achieved a qualification in pharmaceutical sciences in 2007. He furthered his education with various programs, including a management study at Fondazione ISTUD-Stresa and multiple marketing and regulatory affairs courses at institutions such as SDA Bocconi and Roche.
Skills and Expertise
Giuseppe Rizzi possesses a range of skills that enhance his effectiveness in marketing and management. He demonstrates strong financial and business acumen, along with expertise in negotiation, sales analysis, communication, and marketing strategy. His background equips him to navigate the complexities of the pharmaceutical industry, particularly in the oncology sector.
Career Development and Training
Throughout his career, Giuseppe Rizzi has engaged in various training and development programs. He completed the Market Access Academy at SDA Bocconi in 2014 and participated in the Real World Evidence Academy at Roche in 2015. His commitment to professional growth is evident in his continuous pursuit of knowledge in regulatory affairs, project management, and leadership.